PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia

To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.

Detalles Bibliográficos
Autores Principales: Prieto, VA, Reyes, JM, Lopez-Cabra, C, Diaz, JA, Urrego-Novoa
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/25997
https://doi.org/10.1016/j.jval.2016.03.1586
Descripción
Sumario:To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.